You are here

AusPAR: Risankizumab

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

12 February 2020
AusPAR Details
AusPAR
Active Ingredient
Risankizumab
Product Name
Skyrizi
Sponsor
AbbVie Pty Ltd
Submission Number
PM-2018-01889-1-1
Submission Type
New biological entity
Decision
Approved
AusPAR Date
22 January 2020
Publication Date

12 February 2020